Abstract Library

#4593 Excellent response to Ac-225 DOTATATE therapy in a patient with small cell lung cancer

Introduction: Peptide receptor radionuclide therapy (PRRT) is a validated treatment for patients with NETs overexpressing somatostatin receptors (SSTR). IHC analysis indicates that up to 50% of small cell lung cancer (SCLC) tumours are SSTR2 positive and thus can be targeted by SSR imaging and PRRT. Therapy with α-emitting radionuclides, such as Ac225, may offer several advantages over β-emitters by having higher energy transfer and more effective cancer cell death.

Conference:

Presenting Author: Tuncel M

Authors: Tuncel M, Türkan C, Eryılmaz Y, Pala A, Kılıçkap S,

Keywords: Ac-225 DOTATATE, Small Cell lung cancer, PET, somatostatin receptor, PRRT,

#3653 Neuroendocrine urological tumors – Experience of the medical oncology department of the hospital November 1st, 1954, in Oran (Algeria)

Introduction: Neuroendocrine tumors (NET) are mainly located in the digestive tract (85%) and the lung (10%). The other localizations are rare, notably at the urological tract with an uncertain prognosis. At diagnostic, these tumors are often in the metastatic stage. Their treatment is based on chemotherapy (platinum drug).

Conference:

Presenting Author:

Authors: Kehili H, Bengueddache A, Boumansour N, Kaid M, Benabdellah H,

Keywords: neuroendocrine urological tumor, poor prognosis,

#3406 Neoadjuvant treatment in locally advanced pancreatic neuroendocrine tumor G3

Introduction: Bordeline or locally advanced pancreatic neuroendocrine tumors are potentially resectable in selected cases. The role of neoadjuvant chemotherapy has not been established, and there are published only few small studies dealing with this issue.

Conference:

Presenting Author: Pindura M

Authors: Pindura M, Kyčina R, Palkoci B, Nosakova L, Uhrík P,

Keywords: pancreatic neuroendocrine tumor, neoadjuvant treatment, surgery, locally advanced neuroendocrine pancreatic tumor,

#3375 Neuroendocrine tumors associated with ovarian teratoma – One centre experience

Introduction: Ovarian teratomas are frequent gynaecological finding in contrary to ovarian NETs which comprise only 0.1% of all ovarian neoplasms. In contrast to other gynaecological organs like cervix, endometrium vagina or vulva in which the common type of NENs is NECs, in case of ovarian carcinoid the prognosis remains good.

Conference:

Presenting Author: Opalinska M

Authors: Opalinska M, Sowa-Staszczak A, Olearskaa H, Ulatowska-Bialas M, Gilis-Januszewska A,

Keywords: ovarian carcinoid, NET, teratoma, outcome,

#3318 Neuroendocrine tumors in young adult patients - Epidemiological profile, clinical aspects and prognostic factors

Introduction: Neuroendocrine tumors (NETs) comprise a rare disease. However, an increase in the number of cases in young-onset (18-40 years old) NETs (YONET) has been observed in our clinical practice. The data about YONETs profile are scarce.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Zanco Fogassa C

Authors: Fogassa C, Camandaroba M, Tanaka H, Felismino T, Riechelmann R,

Keywords: young-onset NETs, NET, gastroenteropancreatic NETs,